Case details

CCENT/2009/7 - MEDTRONIC/ COREVALVE

Corevalve

established in 2001 under the laws of the State of Delaware, USA, the company develops and markets systems for transcatheter aortic valve replacement. Corevalve has a single subsidiary in Europe, CoreValve Europe BV, in Breda, the Netherlands. Corevalve does not market its products directly in Portugal but rather through a distributor, Endovascular - Dispositivos Médicos Lda.

Medtronic Inc

a company registered under the laws of the State of Minnesota, USA, and quoted on the NYSE (New York Stock Exchange); its main centre of activity is located in the State of Minnesota. Medtronic operates worldwide in the field of medical technology, offering products, therapies and services for the treatment of various diseases. It is organised under six business areas: (i) treatment of cardiac rhythm disorders; (ii) neurological and spine disorders; (iii) neuromodulation; (iv) ear, nose and throat; (v) diabetes; and (vi) cardiovascular. In Portugal, Medtronic operates through its subsidiaries, Medtronic Portugal - Comércio e Distribuição de Aparelhos Médicos Lda and Vitatron Portugal - Comercio e Distribuição de Dispositivos Médicos Lda.

Art. 9(1)(a) (Law 18)

Market share

Conglomerate

Closed

Phase 1

Non-opposition

Publication of the announcement